Ki67 and proliferation in breast cancer

Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer

(2012) Z M A Mohammed et al.   BRITISH JOURNAL OF CANCER

Is Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer?

(2012) Alan S. Coates et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

(2011) Elisabeth Luporsi et al.   BREAST CANCER RESEARCH AND TREATMENT

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score

(2011) S Sahebjam et al.   BRITISH JOURNAL OF CANCER

Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

(2011) Jack Cuzick et al.   JOURNAL OF CLINICAL ONCOLOGY

Independent Prognostic Value of Screen Detection in Invasive Breast Cancer

(2011) Stella Mook et al.   JNCI-Journal of the National Cancer Institute

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups

(2010) Mohammed A. Aleskandarany et al.   BREAST CANCER RESEARCH AND TREATMENT

Comparative validation of the SP6 antibody to Ki67 in breast cancer

(2010) L. Zabaglo et al.   JOURNAL OF CLINICAL PATHOLOGY

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Diagnostic evaluation of papillary lesions of the breast on core biopsy

(2010) Nirmala Pathmanathan et al.   MODERN PATHOLOGY

Deconstructing the molecular portraits of breast cancer

(2010) Aleix Prat et al.   Molecular Oncology

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast

(2009) Nirmala Pathmanathan et al.   PATHOLOGY

Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients

(2008) R. Stuart-Harris et al.   BREAST

Molecular Grading of Ductal Carcinoma In situ of the Breast

(2008) R. L. Balleine et al.   CLINICAL CANCER RESEARCH

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

(2008) Giuseppe Viale et al.   JOURNAL OF CLINICAL ONCOLOGY

Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

(2008) F. Penault-Llorca et al.   ONCOLOGIST